Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Global Lucentis (Ranibizumab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -2.7% from 2023 to 2029. United States market for Lucentis (Ranibizumab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Humira Biosimilar Market Growth 2023-2029
... CAGR of 13.0% from 2023 to 2029. The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars ... Read More
-
Global Herceptin (Trastuzumab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 5.0% from 2023 to 2029. United States market for Herceptin (Trastuzumab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Bevacizumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -15.0% from 2023 to 2029. United States market for Bevacizumab Monoclonal Antibody Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Epogen and Biosimilar Market Growth 2023-2029
... at a CAGR of -3.3% from 2023 to 2029. United States market for Epogen and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Neulasta (Pegfilgrastim) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 6.7% from 2023 to 2029. United States market for Neulasta (Pegfilgrastim) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Adalimumab (Humira) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -5.3% from 2023 to 2029. The expiration of patents for adalimumab (Humira) has emerged as a significant driver in the biosimilar market. Adalimumab is a widely used biologic medication ... Read More
-
Global Thyrogen and Biosimilar Market Growth 2023-2029
... at a CAGR of 16.3% from 2023 to 2029. United States market for Thyrogen and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Avastin Biosimilar Market Growth 2023-2029
... CAGR of -15.0% from 2023 to 2029. United States market for Avastin Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through ... Read More
-
Global Enbrel (Etanercept) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 3.4% from 2023 to 2029. United States market for Enbrel (Etanercept) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Remicade (Infliximab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 5.8% from 2023 to 2029. United States market for Remicade (Infliximab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Rituxan (Rituximab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 3.6% from 2023 to 2029. United States market for Rituxan (Rituximab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Enbrel (Etanercept) Biosimilar Market Growth 2023-2029
... at a CAGR of 4.8% from 2023 to 2029. United States market for Enbrel (Etanercept) Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Adalimumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 13.0% from 2023 to 2029. The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. ... Read More
-
Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... a number of factors such as patent expires of blockbuster biological drugs, lower prices, rising prevalence of chronic diseases, and cost-saving initiatives from governments and third-party payers. Catalyzed by these factors, the market is expected ... Read More
-
Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 303.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of ... Read More
-
Global Biobetters Market - 2023-2030
... global biobetters market is exhibiting at a CAGR of 8.5% during the forecast period (2023-2030). The market trends of biobetters are PEGylation fusion proteins, EKylation, XTEN technology, Pasylation, and so on. Fusion proteins are created ... Read More
-
Biosimilar Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type
... CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented from ... Read More
-
Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
... and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030 Global Generic Pharmaceuticals Market is valued ... Read More
-
Global Biosimilar Monoclonal Antibodies Market Research Report 2023(Status and Outlook)
... produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic ... Read More
-
Global Biosimilars Market Research Report 2023(Status and Outlook)
... standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original ""innovator"" products and can be manufactured when the original product's patent expires. Reference to the ... Read More
-
Haptic Technology Market by Feedback Type (Tactile, Force), Component (Hardware (Actuators, Drivers & Microcontrollers) Software), Application (Consumer Devices, Automotive & Transportation, Commercial & Industrial) and Region - Global Forecast to 2028
... is projected to reach USD 5.0 billion by 2028 from USD 4.2 billion in 2023, at a CAGR of 3.7% from 2023 to 2028. The major factors driving the market growth of the haptic technology ... Read More
-
Global Biosimilars Market Report and Forecast 2023-2031
... during the forecast period of 2023-2031, likely to attain a value of USD 105.1 billion by 2031. Biosimilars Market: Introduction and Application Biosimilars are biological products that are highly similar to an already approved and ... Read More
-
2023 Global: Biosimilar Contract Manufacturing - Innovative Markets Forecast (2029) report
... 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using regression ... Read More
-
North America Human Insulin Drugs Market - By Product (Human Insulin, Basal Insulin, Bolus Insulin, Insulin Combinations, Biosimilar Insulins); By Application (Product I Diabetes, Product II Diabetes); By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Landscape & Forecast, 2019–2029 North America Human Insulin Drugs Market Size Grows Steadily to Touch USD 10.3 Billion by 2029 North America human insulin drugs market is flourishing because of an increasing prevalence of type ... Read More
Research Assistance
